| __timestamp | Protagonist Therapeutics, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 7459000 | 1488000000 |
| Thursday, January 1, 2015 | 11831000 | 1525000000 |
| Friday, January 1, 2016 | 25705000 | 2111000000 |
| Sunday, January 1, 2017 | 46181000 | 1848000000 |
| Monday, January 1, 2018 | 59497000 | 1213000000 |
| Tuesday, January 1, 2019 | 65003000 | 1010000000 |
| Wednesday, January 1, 2020 | 74506000 | 997000000 |
| Friday, January 1, 2021 | 126006000 | 967000000 |
| Saturday, January 1, 2022 | 126215000 | 838000000 |
| Sunday, January 1, 2023 | 120161000 | 953000000 |
| Monday, January 1, 2024 | 998000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Teva Pharmaceutical Industries Limited and Protagonist Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment.
Teva, a global leader, has consistently allocated substantial resources to R&D, peaking in 2016 with a 63% increase from 2014. Despite a gradual decline, Teva's 2023 investment remains significant, underscoring its commitment to innovation.
Conversely, Protagonist Therapeutics has shown remarkable growth in R&D spending, skyrocketing by over 1,500% from 2014 to 2023. This surge reflects the company's aggressive pursuit of novel therapies.
These trends highlight the diverse strategies in the pharmaceutical industry, where both steady and aggressive R&D investments can drive success.
R&D Insights: How Eli Lilly and Company and Protagonist Therapeutics, Inc. Allocate Funds
Comparing Innovation Spending: Novartis AG and Teva Pharmaceutical Industries Limited
Research and Development Investment: Teva Pharmaceutical Industries Limited vs Summit Therapeutics Inc.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Rhythm Pharmaceuticals, Inc.
R&D Insights: How Teva Pharmaceutical Industries Limited and HUTCHMED (China) Limited Allocate Funds
Comparing Innovation Spending: Teva Pharmaceutical Industries Limited and Ligand Pharmaceuticals Incorporated
Research and Development Investment: ADMA Biologics, Inc. vs Protagonist Therapeutics, Inc.
R&D Insights: How CymaBay Therapeutics, Inc. and Protagonist Therapeutics, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Protagonist Therapeutics, Inc.
Analyzing R&D Budgets: Perrigo Company plc vs Protagonist Therapeutics, Inc.
ImmunityBio, Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Protagonist Therapeutics, Inc. vs Xencor, Inc.